Cancer Imaging· 2026Q1
Association of post-treatment ⁹⁰Y PET/CT–derived mean tumor absorbed dose with treated-lesion progression-free survival after glass-microsphere radioembolization for hepatocellular carcinoma
- 0citations
- Q1SCImago
- 2026year
Short summary
A post-treatment Yttrium-90 PET/CT–derived mean tumor absorbed dose exceeding 468 Gy is associated with improved progression-free survival in large (>8 cm) hepatocellular carcinomas treated with radioembolization.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Hepatology
HepatologyMedicine